Selected research
Industry Research
Epigenome Analysis Services Industry Research Report 2026
Market perspective
The global Epigenome Analysis Services market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Epigenome Analysis Services market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Epigenome Analysis Services market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Epigenome Analysis Services market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Epigenome Analysis Services include Cellcentric, Syndax, Illumina, Merck, QIAGEN, F. Hoffmann-La Roche, Eisai, Abcam and Diagenode, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Epigenome Analysis Services market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Epigenome Analysis Services.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Epigenome Analysis Services Market by Company
Cellcentric
Syndax
Illumina
Merck
QIAGEN
F. Hoffmann-La Roche
Eisai
Abcam
Diagenode
Active Motif
Zymo Research Corporation
Thermo Fisher Scientific
Enzo Life Sciences
EpiGentek Group
New England Biolabs
Epizyme
Domainex
Agilent Technologies
AsisChem
Epigenome Analysis Services Segment by Type
DNA Methylation Analysis
Analysis of DNA Interactions
Chromatin Accessibility
Conformation Assays
Epigenome Analysis Services Segment by Application
Research Institutes
Pharmaceutical Companies
Biotechnology Companies
Others
Epigenome Analysis Services Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Epigenome Analysis Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Epigenome Analysis Services and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Epigenome Analysis Services.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Epigenome Analysis Services companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- DNA Methylation Analysis
- Analysis of DNA Interactions
- Chromatin Accessibility
- Conformation Assays
Applications
- Research Institutes
- Pharmaceutical Companies
- Biotechnology Companies
- Others
Companies covered
- Cellcentric
- Syndax
- Illumina
- Merck
- QIAGEN
- F. Hoffmann-La Roche
- Eisai
- Abcam
- Diagenode
- Active Motif
- Zymo Research Corporation
- Thermo Fisher Scientific
- Enzo Life Sciences
- EpiGentek Group
- New England Biolabs
- Epizyme
- Domainex
- Agilent Technologies
- AsisChem
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Epigenome Analysis Services by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 DNA Methylation Analysis
- 2.2.3 Analysis of DNA Interactions
- 2.2.4 Chromatin Accessibility
- 2.2.5 Conformation Assays
- 2.3 Epigenome Analysis Services by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Research Institutes
- 2.3.3 Pharmaceutical Companies
- 2.3.4 Biotechnology Companies
- 2.3.5 Others
- 2.4 Assumptions and Limitations
3 Epigenome Analysis Services Breakdown Data by Type
- 3.1 Global Epigenome Analysis Services Historic Market Size by Type (2021-2026)
- 3.2 Global Epigenome Analysis Services Forecasted Market Size by Type (2027-2032)
4 Epigenome Analysis Services Breakdown Data by Application
- 4.1 Global Epigenome Analysis Services Historic Market Size by Application (2021-2026)
- 4.2 Global Epigenome Analysis Services Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Epigenome Analysis Services Market Perspective (2021-2032)
- 5.2 Global Epigenome Analysis Services Growth Trends by Region
- 5.2.1 Global Epigenome Analysis Services Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Epigenome Analysis Services Historic Market Size by Region (2021-2026)
- 5.2.3 Epigenome Analysis Services Forecasted Market Size by Region (2027-2032)
- 5.3 Epigenome Analysis Services Market Dynamics
- 5.3.1 Epigenome Analysis Services Industry Trends
- 5.3.2 Epigenome Analysis Services Market Drivers
- 5.3.3 Epigenome Analysis Services Market Challenges
- 5.3.4 Epigenome Analysis Services Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Epigenome Analysis Services Players by Revenue
- 6.1.1 Global Top Epigenome Analysis Services Players by Revenue (2021-2026)
- 6.1.2 Global Epigenome Analysis Services Revenue Market Share by Players (2021-2026)
- 6.2 Global Epigenome Analysis Services Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Epigenome Analysis Services Head Office and Area Served
- 6.4 Global Epigenome Analysis Services Players, Product Type & Application
- 6.5 Global Epigenome Analysis Services Manufacturers Established Date
- 6.6 Global Epigenome Analysis Services Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Epigenome Analysis Services Market Size (2021-2032)
- 7.2 North America Epigenome Analysis Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Epigenome Analysis Services Market Size by Country (2021-2026)
- 7.4 North America Epigenome Analysis Services Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Epigenome Analysis Services Market Size (2021-2032)
- 8.2 Europe Epigenome Analysis Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Epigenome Analysis Services Market Size by Country (2021-2026)
- 8.4 Europe Epigenome Analysis Services Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Epigenome Analysis Services Market Size (2021-2032)
- 9.2 Asia-Pacific Epigenome Analysis Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Epigenome Analysis Services Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Epigenome Analysis Services Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Epigenome Analysis Services Market Size (2021-2032)
- 10.2 South America Epigenome Analysis Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Epigenome Analysis Services Market Size by Country (2021-2026)
- 10.4 South America Epigenome Analysis Services Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Epigenome Analysis Services Market Size (2021-2032)
- 11.2 Middle East & Africa Epigenome Analysis Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Epigenome Analysis Services Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Epigenome Analysis Services Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Cellcentric
- 12.1.1 Cellcentric Company Information
- 12.1.2 Cellcentric Business Overview
- 12.1.3 Cellcentric Revenue in Epigenome Analysis Services Business (2021-2026)
- 12.1.4 Cellcentric Epigenome Analysis Services Product Portfolio
- 12.1.5 Cellcentric Recent Developments
- 12.2 Syndax
- 12.2.1 Syndax Company Information
- 12.2.2 Syndax Business Overview
- 12.2.3 Syndax Revenue in Epigenome Analysis Services Business (2021-2026)
- 12.2.4 Syndax Epigenome Analysis Services Product Portfolio
- 12.2.5 Syndax Recent Developments
- 12.3 Illumina
- 12.3.1 Illumina Company Information
- 12.3.2 Illumina Business Overview
- 12.3.3 Illumina Revenue in Epigenome Analysis Services Business (2021-2026)
- 12.3.4 Illumina Epigenome Analysis Services Product Portfolio
- 12.3.5 Illumina Recent Developments
- 12.4 Merck
- 12.4.1 Merck Company Information
- 12.4.2 Merck Business Overview
- 12.4.3 Merck Revenue in Epigenome Analysis Services Business (2021-2026)
- 12.4.4 Merck Epigenome Analysis Services Product Portfolio
- 12.4.5 Merck Recent Developments
- 12.5 QIAGEN
- 12.5.1 QIAGEN Company Information
- 12.5.2 QIAGEN Business Overview
- 12.5.3 QIAGEN Revenue in Epigenome Analysis Services Business (2021-2026)
- 12.5.4 QIAGEN Epigenome Analysis Services Product Portfolio
- 12.5.5 QIAGEN Recent Developments
- 12.6 F. Hoffmann-La Roche
- 12.6.1 F. Hoffmann-La Roche Company Information
- 12.6.2 F. Hoffmann-La Roche Business Overview
- 12.6.3 F. Hoffmann-La Roche Revenue in Epigenome Analysis Services Business (2021-2026)
- 12.6.4 F. Hoffmann-La Roche Epigenome Analysis Services Product Portfolio
- 12.6.5 F. Hoffmann-La Roche Recent Developments
- 12.7 Eisai
- 12.7.1 Eisai Company Information
- 12.7.2 Eisai Business Overview
- 12.7.3 Eisai Revenue in Epigenome Analysis Services Business (2021-2026)
- 12.7.4 Eisai Epigenome Analysis Services Product Portfolio
- 12.7.5 Eisai Recent Developments
- 12.8 Abcam
- 12.8.1 Abcam Company Information
- 12.8.2 Abcam Business Overview
- 12.8.3 Abcam Revenue in Epigenome Analysis Services Business (2021-2026)
- 12.8.4 Abcam Epigenome Analysis Services Product Portfolio
- 12.8.5 Abcam Recent Developments
- 12.9 Diagenode
- 12.9.1 Diagenode Company Information
- 12.9.2 Diagenode Business Overview
- 12.9.3 Diagenode Revenue in Epigenome Analysis Services Business (2021-2026)
- 12.9.4 Diagenode Epigenome Analysis Services Product Portfolio
- 12.9.5 Diagenode Recent Developments
- 12.10 Active Motif
- 12.10.1 Active Motif Company Information
- 12.10.2 Active Motif Business Overview
- 12.10.3 Active Motif Revenue in Epigenome Analysis Services Business (2021-2026)
- 12.10.4 Active Motif Epigenome Analysis Services Product Portfolio
- 12.10.5 Active Motif Recent Developments
- 12.11 Zymo Research Corporation
- 12.11.1 Zymo Research Corporation Company Information
- 12.11.2 Zymo Research Corporation Business Overview
- 12.11.3 Zymo Research Corporation Revenue in Epigenome Analysis Services Business (2021-2026)
- 12.11.4 Zymo Research Corporation Epigenome Analysis Services Product Portfolio
- 12.11.5 Zymo Research Corporation Recent Developments
- 12.12 Thermo Fisher Scientific
- 12.12.1 Thermo Fisher Scientific Company Information
- 12.12.2 Thermo Fisher Scientific Business Overview
- 12.12.3 Thermo Fisher Scientific Revenue in Epigenome Analysis Services Business (2021-2026)
- 12.12.4 Thermo Fisher Scientific Epigenome Analysis Services Product Portfolio
- 12.12.5 Thermo Fisher Scientific Recent Developments
- 12.13 Enzo Life Sciences
- 12.13.1 Enzo Life Sciences Company Information
- 12.13.2 Enzo Life Sciences Business Overview
- 12.13.3 Enzo Life Sciences Revenue in Epigenome Analysis Services Business (2021-2026)
- 12.13.4 Enzo Life Sciences Epigenome Analysis Services Product Portfolio
- 12.13.5 Enzo Life Sciences Recent Developments
- 12.14 EpiGentek Group
- 12.14.1 EpiGentek Group Company Information
- 12.14.2 EpiGentek Group Business Overview
- 12.14.3 EpiGentek Group Revenue in Epigenome Analysis Services Business (2021-2026)
- 12.14.4 EpiGentek Group Epigenome Analysis Services Product Portfolio
- 12.14.5 EpiGentek Group Recent Developments
- 12.15 New England Biolabs
- 12.15.1 New England Biolabs Company Information
- 12.15.2 New England Biolabs Business Overview
- 12.15.3 New England Biolabs Revenue in Epigenome Analysis Services Business (2021-2026)
- 12.15.4 New England Biolabs Epigenome Analysis Services Product Portfolio
- 12.15.5 New England Biolabs Recent Developments
- 12.16 Epizyme
- 12.16.1 Epizyme Company Information
- 12.16.2 Epizyme Business Overview
- 12.16.3 Epizyme Revenue in Epigenome Analysis Services Business (2021-2026)
- 12.16.4 Epizyme Epigenome Analysis Services Product Portfolio
- 12.16.5 Epizyme Recent Developments
- 12.17 Domainex
- 12.17.1 Domainex Company Information
- 12.17.2 Domainex Business Overview
- 12.17.3 Domainex Revenue in Epigenome Analysis Services Business (2021-2026)
- 12.17.4 Domainex Epigenome Analysis Services Product Portfolio
- 12.17.5 Domainex Recent Developments
- 12.18 Agilent Technologies
- 12.18.1 Agilent Technologies Company Information
- 12.18.2 Agilent Technologies Business Overview
- 12.18.3 Agilent Technologies Revenue in Epigenome Analysis Services Business (2021-2026)
- 12.18.4 Agilent Technologies Epigenome Analysis Services Product Portfolio
- 12.18.5 Agilent Technologies Recent Developments
- 12.19 AsisChem
- 12.19.1 AsisChem Company Information
- 12.19.2 AsisChem Business Overview
- 12.19.3 AsisChem Revenue in Epigenome Analysis Services Business (2021-2026)
- 12.19.4 AsisChem Epigenome Analysis Services Product Portfolio
- 12.19.5 AsisChem Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst